Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Rheumatology and Immunology Research|October 23, 2024
Fibroblast activation protein inhibitor PET/CT as an emerging diagnostic modality in interstitial lung disease and other fibrotic conditionsMihai Tudor Albu, Alexandru-Emil Matei, Jörg H W Distler, et al.
Plos One|November 6, 2009
Screening for microsatellite instability identifies frequent 3'-untranslated region mutation of the RB1-inducible coiled-coil 1 gene in colon tumorsBogdan C Paun, Yulan Cheng, Barbara A Leggett, et al.
Seminars in Nuclear Medicine|July 16, 2022
Advancement and Future Perspective of FAPI PET/CT In Gynecological MalignanciesKatharina Dendl, Stefan A Koerber, Katharina Tamburini, et al.
Seminars in Nuclear Medicine|July 8, 2022
A Role of Non-FDG Tracers in Lung Cancer?Emil Novruzov, Yuriko Mori, Christina Antke, et al.
Npj Imaging|July 3, 2025
Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)Yuriko Mori, Emil Novruzov, Dominik Schmitt, et al.
Cancer|July 30, 2013
Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancerZhe Jin, Zhenfu Zhao, Yulan Cheng, et al.
Cancer|November 14, 2007
Hypermethylation of the somatostatin promoter is a common, early event in human esophageal carcinogenesisZhe Jin, Yuriko Mori, James P Hamilton, et al.
Surgical Case Reports|July 25, 2022
Primary thyroid gland myxofibrosarcoma: a case report and review of the literatureMaria Chara Stylianidi, Lena Haeberle, Matthias Schott, et al.
Reviews in the Neurosciences|July 4, 2020
GABAergic and glutamatergic effects on nigrostriatal and mesolimbic dopamine release in the ratSusanne Nikolaus, Markus Beu, Hans-Jörg Wittsack, et al.
Cancer|March 8, 2005
Prediction of survival in patients with esophageal carcinoma using artificial neural networksFumiaki Sato, Yutaka Shimada, Florin M Selaru, et al.
Pageof 9